Nanoformulation-Based 1,2,3-Triazole Sulfonamides for Anti-Toxoplasma In Vitro Study

Toxoplasma gondii is deemed a successful parasite worldwide with a wide range of hosts. Currently, a combination of pyrimethamine and sulfadiazine serves as the first-line treatment; however, these drugs have serious adverse effects. Therefore, it is imperative to focus on new therapies that produce...

Descripción completa

Detalles Bibliográficos
Autores principales: Arafa, Fadwa M., Said, Heba, Osman, Doaa, Rezki, Nadjet, Aouad, Mohamed R., Hagar, Mohamed, Osman, Mervat, Elwakil, Bassma H., Jaremko, Mariusz, Tolba, Mona Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460005/
https://www.ncbi.nlm.nih.gov/pubmed/37624339
http://dx.doi.org/10.3390/tropicalmed8080401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460005/
https://www.ncbi.nlm.nih.gov/pubmed/37624339
http://dx.doi.org/10.3390/tropicalmed8080401

Ejemplares similares